Clinical Trials Sponsored by Bionime Corporation

Total 6652 results

Bionime Corporation

Not yet recruiting

Effectiveness and Safety of the RIGHTEST Continuous Glucose Monitoring System for Blood Glucose Management in Persons With Diabetes Mellitus

Diabetes Mellitus

United States
Bionime Corporation

Not yet recruiting

Effectiveness and Safety of the RIGHTEST™ Continuous Glucose Monitoring System for Blood Glucose Management in Persons With Diabetes Mellitus

Diabetes Mellitus
Monash University
Caring Pharmacy; Bionime Corporation

Active, not recruiting

Diabetes Prevention and Prediabetes Management in Adult (PRIME)

PreDiabetes

Malaysia
Monash University
Caring Pharmacy; Bionime Corporation; Tigas Pharma

Active, not recruiting

Prevention and Treatment of Diabetes in Adults

PreDiabetes

Malaysia
BioLite, Inc.
American BriVision Corporation

Not yet recruiting

A Phase I/II Study of PDC-1421 for Treating Depression in Cancer Patients

Major Depressive Disorder

United States
David Birnie

Completed

The Ottawa AF Cardioversion Protocol

Atrial Fibrillation

Canada
Bayer
Corporación Bonima S.A. de C.V.

Completed

Cross-over Study to Prove Bioequivalence Between Two Brands of Cefalexin Capsules

Anti-Infective Agents

Mexico
Biosite

Completed

Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT II)

Heart Failure

United States
Biosite

Withdrawn

Clinical Performance Evaluation of the Cholestech LDX Cardiac hsCRP Test (CLEAR) (CLEAR)

Cardiovascular Disease

United States
Biosite

Withdrawn

Rapid Assessment of Cardiac Markers for the Evaluation of Acute Coronary Syndrome (RACE-ACS)

Acute Coronary Syndrome

United States
Biosite

Completed

User Performance Evaluation of the INRatio® Prothrombin Time (PT) Monitoring System With a New INRatio Test Strip Designed for Low Sample Volume and Heparin Insensitivity (ECLIPSE-02)

Oral Anticoagulation

United States
Biosite

Completed

Multi-Markers In the Diagnosis of Acute Coronary Syndrome (Midas 3)

Acute Coronary Syndrome

United States
Biosite

Completed

Neutrophil Gelatinase-associated Lipocalin (NGAL) Evaluation in Emergency Department (ED) All-Comers

Acute Kidney Injury

Italy
Biosite

Completed

Neutrophil Gelatinase-associated Lipcalin(NGAL): A Novel Blood Marker for Determining the Risk of Developing Contrast-Induced Nephopathy (ENCINO)

Cardiovascular Surgery With Coronary Angiography

United States
Biosite

Completed

Evaluation of Neutrophil Gelatinase-associated Lipocalin (NGAL) in Early and Evolving Acute Kidney Injury (EVOLVE)

Kidney Failure, Acute

United States, Canada
Bayer
Corporación Bonima S.A. de C.V.

Completed

Cross-over Study to Prove Bioequivalence Between Two Brands of Cefalexin Suspension

Anti-Infective Agents

Mexico
Bayer
Corporación Bonima S.A. de C.V.

Completed

Cross Over Study to Prove Bioequivalence Between Two Brands of Cefalexin Suspension

Anti-Infective Agents

Mexico
Biosite

Completed

Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU (REAL-ICU)

Acute Kidney Injury

United States, Canada
Biosite

Completed

SHORTness of Breath In the Emergency Department (SHORTIE)

Heart Failure | Pulmonary Embolism | Acute Myocardial Infarction

United States
Biosite

Withdrawn

Evaluation of Serial Troponin and Cardiac Multimarkers at the Point of Care in the Emergency Department (ESTIMATE)

Chest Pain | Acute Coronary Syndrome | Acute Myocardial Infarction

United States
Biosite

Completed

Evaluation of the Accuracy and Precision of the INRatio® Prothrombin Time (PT) Monitoring System With New INRatio Test Strip Designed for Low Sample Volume and Heparin Insensitivity (ECLIPSE-01)

Atrial Fibrillation | Deep Vein Thrombosis | Pulmonary Embolism

United States
Biosite

Completed

Triage Now: an Observational, Prospective Multimarker Study of Biomarkers in Patients Presenting With Chest Pain

Myocardial Infarction | Acute Coronary Syndrome

Germany
Biosite

Completed

BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)

Stroke | Stroke Mimic(Conditions Presenting With Stroke-like Conditions)

United States, Canada, Germany, Switzerland, United Kingdom
Biosite

Withdrawn

Multi-marker INDex for the Risk Assessment of Sepsis in the Emergency departmenT (MINDSET) (MINDSET)

Sepsis

United States
Biosite

Terminated

Rapid Assessment of Bedside BNP In Treatment of Heart Failure (RABBIT)

Heart Failure

United States
Biosite

Completed

Evaluation of the Accuracy of the INRatio Prothrombin Time (PT) Monitoring System With a New Test Strip for the Oral Anticoagulation Therapy Patient in the Presence of Heparin and Low Molecular Weight Heparin (e.g., Enoxaparin or Dalteparin) (ECLIPSE 03)

Coagulation

United States
Biosite

Completed

Neutrophil Gelatinase-Associated Lipcalin (NGAL) Evaluation Along With B-Type Natriuretic Peptide in Acutely Decompensated HF (GALLANT)

Acute Decompensated Heart Failure

United States, Netherlands, Switzerland
Biosite

Completed

Myeloperoxidase and Multi-Markers In the Diagnosis of Diagnoses of Acute Coronary Syndrome (MIDAS) - Sample Procurement

Acute Coronary Syndrome (ACS)

United States
Advanced Bionics AG
Advanced Bionics

Completed

Evaluation of Different Phone Solutions in CI and Hearing Aid Users and Bimodal Recipients (PhoneCIHA)

Hearing Loss, Binaural | Hearing Loss, Monaural

Switzerland
Ekso Bionics

Completed

Exoskeleton Treatment of Deconditioning Due to Limited Ambulation Caused by Illness or Injury

Debility Due to Disease

United States
Advanced Bionics

Terminated

Implantation of the HiRes90K™ Advantage Cochlear Implant With HiFocus™ Mid-Scala and Development of a Combined Electric and Acoustic Stimulation Technology in Adults With Partial Deafness

Otorhinolaryngologic Diseases | Ear Diseases | Hearing Loss | Hearing Disorders | Partial Deafness

United States
Advanced Bionics

Completed

Clinical Evaluation of a Cochlear Implant Sound Processor

Otorhinolaryngologic Diseases | Ear Diseases | Hearing Loss | Hearing Disorders

United States
Advanced Bionics

Completed

ClearVoice Sound-processing Strategy for AB HiRes 120 Cochlear Implant Users

Implant

United States, Canada
Advanced Bionics

Completed

Evaluation of a HiRes™ Optima Sound Processing Strategy for the HiResolution™ Bionic Ear

Severe to Profound Hearing Loss | in Adult Users of Advanced Bionics HiResolution™ Bionic Ear System

United States
Bionode, LLC

Unknown

Clinical Study Of The Bionode System In Subjects With Elevated IOP

Unmedicated IOP Before and After Treatment

Canada
Advanced Bionics

Terminated

Evaluation of Hearing Preservation in Adults With Partial Low-Frequency Hearing Implanted With the HiFocus™ Mid-Scala Electrode

Otorhinolaryngologic Diseases | Ear Diseases | Hearing Loss | Hearing Disorders | Deafness

Canada
Advanced Bionics

Completed

Bilateral Benefit in Adult Users of the HiRes 90K Bionic Ear System

Hearing Loss

United States
Advanced Bionics

Unknown

Bilateral Cochlear Implant Benefit in Young Children

Hearing Loss

United States, Canada
BioFire Diagnostics, LLC
BioFire Defense LLC

Completed

Prospective Clinical Evaluation of the FilmArray® NGDS Warrior Panel

Evaluation of Test Panel

United States
BioLite, Inc.

Not yet recruiting

Phase I/II, Evaluate the Safety and Efficacy of BLEX 404 With Docetaxel in Patients With Advanced/Metastatic Triple Negative Breast Cancer.

Triple Negative Breast Cancer
Advanced Bionics

Completed

Non-significant Risk Study of a Cochlear Implant Headpiece

Hearing Loss | Sensorineural Hearing Loss

United States
Advanced Bionics

Completed

Benefits of the HiResolution Bionic Ear System in Adults With Asymmetric Hearing Loss

Otorhinolaryngologic Diseases | Ear Diseases | Hearing Loss | Hearing Disorders | Asymmetrical Hearing Loss | Single-Sided Deafness

United States
BioLite, Inc.

Completed

A Phase II Study of PDC-1421 Capsule to Evaluate the Safety and Efficacy in Patients With Major Depressive Disorder

Major Depressive Disorder

Taiwan, United States
BioLite, Inc.

Not yet recruiting

A Study of BLEX 404 Oral Liquid in Patients With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-Risk Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML)

Myelodysplastic Syndrome (MDS)
Advanced Bionics

Enrolling by invitation

Baseline Performance and Fitting Parameters for Sonova Products

Ear Diseases | Hearing Loss | Hearing Disorders | Otolaryngological Disease

United States
Ekso Bionics

Terminated

Investigational Study of the Ekso for High-Dosage Use by Individuals With SCI in a Non-Clinical Environment

Spinal Cord Injuries

United States
Advanced Bionics

Completed

Evaluation of Remote Fitting in Adult and Pediatric Users of the HiResolution Bionic Ear System

Ear Diseases | Hearing Loss | Hearing Disorders | Otolaryngological Disease

United States
BioLite, Inc.

Completed

A Study of PDC-1421 Treatment in Adult Patients With Attention-Deficit Hyperactivity Disorder (ADHD)

Attention-Deficit Hyperactivity Disorder (ADHD)

United States
BioLite, Inc.

Completed

A Dose Escalation Phase I Study of PDC-1421 Capsule Targeting in Depression

Major Depressive Disorder

Taiwan
US Bionics

Completed

Phoenix Exoskeleton for SCI Users

SCI - Spinal Cord Injury

Hong Kong, United States

3

Subscribe